CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,638 enrolled
Drug / intervention
10% povidone-iodine (1% free iodine) in purified water +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03385304
NCT03385304Phase 4Completed

Aqueous-PREP: A Pragmatic Randomized Trial Evaluating Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures

University of Maryland, Baltimore·interventional·Posted Dec 28, 2017·Updated Mar 31, 2023

In Brief

A Phase 4 clinical trial evaluating 10% povidone-iodine (1% free iodine) in purified water and 4% chlorhexidine gluconate (CHG) in purified water for Surgical Site Infection and 2 related conditions. Completed, enrolled 1,638 participants across 15 sites in 3 countries.

Detailed Summary

The prevention of infection is the single most important goal influencing peri-operative care of patients with open fractures. Standard practice in the management of open fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for open fracture surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, Spain, United States

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedDec 28, 2017
Enrollment StartApr 8, 2018
Primary CompletionOct 19, 2021
Study CompletionJun 27, 2022
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 8.5 years ago

Interventions

10% povidone-iodine (1% free iodine) in purified waterdrug

Participant recruitment will begin with the clinical sites using their assigned pre-operative antiseptic skin solution for all open fracture surgeries for a two-month period.

4% chlorhexidine gluconate (CHG) in purified waterdrug

Once the first intervention phase is completed, each site will crossover to the opposite study solution. Each site will need to develop local procedures to ensure a successful crossover. They will use the second solution for all open fracture surgeries for a two-month period, and will then crossover back to the solution in the first intervention phase.